NCT02496611View on ClinicalTrials.gov

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions
Severe Obesity
Interventions
DRUG

Weight loss with pharmacotherapy

Participants randomized to the drug intervention group will receive Exenatide extended-release.

DRUG

Weight loss without pharmacotherapy

Participants randomized to the placebo group will receive a placebo.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02496611 - Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity | Biotech Hunter | Biotech Hunter